Keyphrases
HLA-A2
59%
T Cells
58%
T Cell Receptor
58%
MHC Class I
38%
MHC Restriction
33%
TCR Recognition
33%
Drug-resistant Mycobacterium Tuberculosis
33%
Structural Identification
33%
Minor Histocompatibility Antigens
33%
HA-1
33%
Transformed Self
33%
Phosphorylation-dependent Interactions
33%
Endogenous T Cells
33%
Ligand Identification
33%
New Drugs
33%
Phosphopeptides
33%
Next-generation Vaccines
33%
Polymorphism
33%
Antigenic Peptide
33%
Tuberculosis
33%
Mycobacterium Tuberculosis Infection
33%
Inhibitory Receptors
33%
Leukocyte Immune-type Receptors
33%
T-cell Receptor Repertoire
33%
Antigen Targeting
33%
Surface Expression
33%
Tumor Antigen
33%
Phosphorylation
25%
Anti-infective
16%
Susceptible Population
16%
Bacillus Calmette-Guérin Vaccine
16%
New Drug Candidate
16%
Global Burden of Disease
16%
Most Common Cause
16%
Drug Resistance
16%
Clinical Trials
16%
Vaccine Candidate
16%
Cause of Death
16%
Chemotherapy
16%
Etiological Agents
16%
Multidrug-resistant
16%
Antigen-specific
16%
Allorecognition
16%
Antigen Levels
16%
Latent Membrane Protein 1 (LMP1)
15%
MHC Molecules
13%
Hodgkin Lymphoma
11%
Epitope
10%
Prototypic
10%
HLA-A3
8%
Immunological Signature
8%
Novel Peptide
8%
Peptide Binding Affinity
8%
Peptide Binding Site
8%
Phosphate
8%
Protein Phosphorylation
8%
Neoantigen
8%
Differential Display
8%
Major Histocompatibility Complex Molecules
8%
Cancer Cells
8%
MHC Class II
8%
Malignant Transformation
8%
Cancer Immunotherapy
8%
Peptide-MHC Complex
8%
Direct Recognition
8%
Autoreactive T Cells
8%
Suitable Basis
8%
Receptor Triggering
8%
Kinetic Mechanism
8%
Self-antigens
8%
Homozygote
8%
Allogeneic
8%
Transformed Cells
8%
Alloreactive
8%
Therapeutic Targeting
8%
Targeting Peptide
8%
Associated Antigen
8%
Tumor-associated
8%
Antigen Specificity
8%
T-cell Receptor Gene
6%
TCR Gene Therapy
6%
Primary T Cells
6%
Receptor Clusters
5%
Inclusion Bodies
5%
Receptor 1
5%
Leukocytes
5%
Immunoglobulin Domain
5%
Specific T Cells
5%
Immunology and Microbiology
T Cell Receptor
100%
T Cell
88%
Peptides
62%
MHC Restriction
33%
Minor Histocompatibility Antigen
33%
Susceptible Population
33%
Leukocyte Immunoglobulin-Like Receptors
33%
BCG Vaccine
33%
Mycobacterium Tuberculosis
33%
Drug Resistance
33%
Myeloid
33%
Disease Burden
33%
Tumor Antigen
33%
Antigen Specificity
33%
Energy Transfer
33%
Immunogenicity
25%
Allorecognition
22%
Amino Acid
16%
Alloreactive T Cell
11%
Homozygote
11%
Transformed Cell
11%
Immunotherapy
11%
Dimorphism
8%
Graft-Versus-Host Disease
8%
Null Allele
8%
Conformational Transition
8%
Stem Cell Transplantation
8%
Immune Response
8%
Epitope
8%
Receptor Gene
6%
MHC Class I
5%
Leukocyte
5%
Inclusion Bodies
5%
Immunoglobulin Domain
5%
Biochemistry, Genetics and Molecular Biology
T Cell
41%
MHC Class I
38%
Histocompatibility
33%
T Cell Receptor
33%
Myeloid
33%
Copurification
33%
Leukocyte Immunoglobulin-Like Receptors
33%
Phosphopeptide
33%
Immunogenicity
25%
Major Histocompatibility Complex
16%
Arginine
16%
Amino Acids
16%
Protein Phosphorylation
8%
Crystal Structure
8%
Cancer Cell
8%
Malignant Transformation
8%
Binding Affinity
8%
Differential Display
8%
Cancer Immunotherapy
8%
Null Allele
8%
Conformational Change
8%
Stem Cell Transplantation
8%
Immune Response
8%
Immunoglobulin Domain
5%
Dendritic Cell
5%
Leukocyte
5%